Peptide Therapeutics Forum 2024
22.-23. August 2024, Biozentrum Basel
Peptide Therapeutics Forum 2024
22.-23. August 2024, Biozentrum Basel
Posters
[01] Hannah Back, Univserity of Vienna
«Fine-Tuning the Immune-Stimulatory and Cancer Cell Binding Properties of Immune System Engagers (ISErs)»
[02] Elena Rebecca Cotroneo, Göttingen Universität
«Self-Assembly of a Light-Responsive Tryptophan Zipper»
[03] Nathan De Sadeleer, EPFL
«Exploring the membrane permeability of cyclic peptides»
[04] Jérôme Eberhardt, University of Basel
«Combining Bayesian optimization with sequence- or structure-based method for optimization of peptide-protein binding»
[05] Manuel Gemander, Technische Universität Berlin (TU)
«Breaking Antimicrobial Resistance: Albicidins as Innovative Pharmacophores»
[06] Mirja Harms, Ulm University Medical Center
«Fatty acid conjugated EPI-X4 derivatives with increased activity and in vivo stability»
[07] Wendy Hartsock, Aralezbio
«Therapeutically Relevant and Novel Amino Acids from Biocatalysis»
[08] Rahel Heeb, ETH Zurich
«Improving the delivery efficiency of cell penetrating peptides through the incorporation of modified guanidinium prolines»
[09] Oliver Kracker, Corden Pharma
«Flow SPPS – Towards greener and more efficient peptide manufacturing»
[10] Marcel Kulike-Koczula, TU Berlin
«Structural modification of albicidin’s N-terminal fragment: Modulation of antibacterial activity, resistance and solubility»
[11] Xinyan Lu, University of Basel
«A chemical degron system for exploring PALB2 synthetic lethal combinations»
[12] Magoti Masota, EPFL
«Development of TR-FRET assay for high-throughput screening (HTS) of macrocyclic peptide inhibitors against oncogenic APC/Asef proteins interaction»
[13] Gregoire Menoud, EPFL
«High-throughput synthesis and screening of mixture of cyclic peptides»
[14] Basak Olcay, University of Bern
«Exploration of Antimicrobial Peptide Diastereomeric Chemical Space Guided by Machine Learning»
[15] Adeline Schmitt, ETH Zurich
«Nuclear Delivery of Inositol Pyrophosphate Prometabolites Mediated by Short Cationic»
[16] Mischa Schüttel, Orbis Medicines SA
«Next generation orally available macrocycles for challenging GPCR targets in obesity»
[17] Maxwell Sigal, University of Tokyo
«RaPID discovery of α, α-disubstituted α-amino acid-containing α-helical peptides targeting an α-helical protein-protein interaction»
[18] Balint Tamas, University of Zurich
«Development of a self-optimizing platform for flow-based peptide synthesis»
[19] Robert Vacha, Central European Institute of Technology
«Design Guidelines for Antimicrobial Peptides that Kill Antibiotic-Resistant Bacteria via Transmembrane Pores»
[20] Omkar Rajendra Valanju, University of Würzburg
«Molecular basis and regulation of Ankyrin-mediated ligand recruitment to neuronal axonal versus synaptic sites»
[21] Stephanie Vogt, University of Basel
«Breaking the boundaries of a clinically approved cyclic peptide: Development of rodent-active and long-duration analogs»
[22] Samuel Yasmin, University of Bern
«Peptide dendrimers as novel vehicles for mRNA transfection»
[23] Fabian Zeck, Ulm University Medical Center
«Generating improved VIRIP-based HIV-1 gp41 FP inhibitors»
[24] Roman Aschwanden, University of Basel
«Accurate relative binding free energy prediction for cyclic peptides»